Colchicine effectiveness in symptom and inflammation modification in knee osteoarthritis (COLKOA): study protocol for a randomized controlled trial.

dc.contributor.author

Leung, Ying-Ying

dc.contributor.author

Thumboo, Julian

dc.contributor.author

Wong, Bak Siew

dc.contributor.author

Haaland, Ben

dc.contributor.author

Chowbay, Balram

dc.contributor.author

Chakraborty, Bibhas

dc.contributor.author

Tan, Mann Hong

dc.contributor.author

Kraus, Virginia B

dc.coverage.spatial

England

dc.date.accessioned

2015-11-10T22:26:01Z

dc.date.issued

2015-04-30

dc.description.abstract

BACKGROUND: Despite the high prevalence and global impact of knee osteoarthritis (KOA), current treatments are palliative. No disease modifying anti-osteoarthritic drug (DMOAD) has been approved. We recently demonstrated significant involvement of uric acid and activation of the innate immune response in osteoarthritis (OA) pathology and progression, suggesting that traditional gout therapy may be beneficial for OA. We therefore assess colchicine, an existing commercially available agent for gout, for a new therapeutic application in KOA. METHODS/DESIGN: COLKOA is a double-blind, placebo-controlled, randomized trial comparing a 16-week treatment with standard daily dose oral colchicine to placebo for KOA. A total of 120 participants with symptomatic KOA will be recruited from a single center in Singapore. The primary end point is 30% improvement in total Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score at week 16. Secondary end points include improvement in pain, physical function, and quality of life and change in serum, urine and synovial fluid biomarkers of cartilage metabolism and inflammation. A magnetic resonance imaging (MRI) substudy will be conducted in 20 participants to evaluate change in synovitis. Logistic regression will be used to compare changes between groups in an intention-to-treat analysis. DISCUSSION: The COLKOA trial is designed to evaluate whether commercially available colchicine is effective for improving signs and symptoms of KOA, and reducing synovial fluid, serum and urine inflammatory and biochemical joint degradation biomarkers. These biomarkers should provide insights into the underlying mechanism of therapeutic response. This trial will potentially provide data to support a new treatment option for KOA. TRIAL REGISTRATION: The trial has been registered at clinicaltrials.gov as NCT02176460 . Date of registration: 26 June 2014.

dc.identifier

http://www.ncbi.nlm.nih.gov/pubmed/25925674

dc.identifier

10.1186/s13063-015-0726-x

dc.identifier.eissn

1745-6215

dc.identifier.uri

https://hdl.handle.net/10161/10863

dc.language

eng

dc.publisher

Springer Science and Business Media LLC

dc.relation.ispartof

Trials

dc.relation.isversionof

10.1186/s13063-015-0726-x

dc.subject

Administration, Oral

dc.subject

Adult

dc.subject

Aged

dc.subject

Anti-Inflammatory Agents

dc.subject

Biomarkers

dc.subject

Clinical Protocols

dc.subject

Colchicine

dc.subject

Double-Blind Method

dc.subject

Female

dc.subject

Humans

dc.subject

Inflammation Mediators

dc.subject

Intention to Treat Analysis

dc.subject

Knee Joint

dc.subject

Logistic Models

dc.subject

Magnetic Resonance Imaging

dc.subject

Male

dc.subject

Middle Aged

dc.subject

Osteoarthritis, Knee

dc.subject

Pain Measurement

dc.subject

Quality of Life

dc.subject

Recovery of Function

dc.subject

Research Design

dc.subject

Singapore

dc.subject

Surveys and Questionnaires

dc.subject

Synovial Fluid

dc.subject

Time Factors

dc.subject

Treatment Outcome

dc.subject

Young Adult

dc.title

Colchicine effectiveness in symptom and inflammation modification in knee osteoarthritis (COLKOA): study protocol for a randomized controlled trial.

dc.type

Journal article

duke.contributor.orcid

Kraus, Virginia B|0000-0001-8173-8258

pubs.author-url

http://www.ncbi.nlm.nih.gov/pubmed/25925674

pubs.begin-page

200

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Duke

pubs.organisational-group

Duke Molecular Physiology Institute

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Medicine

pubs.organisational-group

Medicine, Rheumatology and Immunology

pubs.organisational-group

Orthopaedics

pubs.organisational-group

Pathology

pubs.organisational-group

School of Medicine

pubs.publication-status

Published online

pubs.volume

16

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Colchicine effectiveness in symptom and inflammation modification in knee osteoarthritis (COLKOA): study protocol for a randomized controlled trial.pdf
Size:
1.1 MB
Format:
Adobe Portable Document Format
Description:
Published version